Inovio Pharmaceuticals, Inc.【INO】 純利益の推移
機能の使い方
|
（単位：千ドル）
|
純利益
|
前年比（％）
|
|
4Q25
|
3,764
|
-119.4%
|
|
3Q25
|
-45,497
|
+80.8%
|
|
2Q25
|
-23,520
|
-27.0%
|
|
1Q25
|
-19,695
|
-35.4%
|
|
4Q24
|
-19,382
|
-22.5%
|
|
3Q24
|
-25,166
|
-25.8%
|
|
2Q24
|
-32,238
|
-9.3%
|
|
1Q24
|
-30,470
|
-25.0%
|
|
4Q23
|
-25,004
|
-54.1%
|
|
3Q23
|
-33,930
|
-10.2%
|
|
2Q23
|
-35,535
|
-67.2%
|
|
1Q23
|
-40,650
|
-48.6%
|
|
4Q22
|
-54,446
|
-49.1%
|
|
3Q22
|
-37,784
|
-37.2%
|
|
2Q22
|
-108,498
|
+32.2%
|
|
1Q22
|
-79,074
|
+45.4%
|
|
4Q21
|
-106,948
|
+339.4%
|
|
3Q21
|
-60,170
|
-413.8%
|
|
2Q21
|
-82,100
|
-36.2%
|
|
1Q21
|
-54,400
|
+67.2%
|
|
4Q20
|
-24,339
|
-35.4%
|
|
3Q20
|
19,171
|
-183.0%
|
|
2Q20
|
-128,700
|
+337.9%
|
|
1Q20
|
-32,542
|
+11.4%
|
|
4Q19
|
-37,663
|
+14.3%
|
|
3Q19
|
-23,091
|
-7.7%
|
|
2Q19
|
-29,388
|
+342.6%
|
|
1Q19
|
-29,220
|
-9.7%
|
|
4Q18
|
-32,963
|
+53.3%
|
|
3Q18
|
-25,016
|
-26.7%
|
|
2Q18
|
-6,640
|
-30.0%
|
|
1Q18
|
-32,351
|
+40.1%
|
|
4Q17
|
-21,507
|
-18.0%
|
|
3Q17
|
-34,135
|
+64.4%
|
|
2Q17
|
-9,480
|
-49.3%
|
|
1Q17
|
-23,086
|
+187.0%
|
|
4Q16
|
-26,234
|
+46.1%
|
|
3Q16
|
-20,760
|
-471.1%
|
|
2Q16
|
-18,705
|
+203.5%
|
|
1Q16
|
-8,043
|
-24.0%
|
|
4Q15
|
-17,953
|
+142.2%
|
|
3Q15
|
5,594
|
-177.9%
|
|
2Q15
|
-6,163
|
-42.5%
|
|
1Q15
|
-10,582
|
-2.2%
|
|
4Q14
|
-7,412
|
-52.0%
|
|
3Q14
|
-7,178
|
-76.8%
|
|
2Q14
|
-10,712
|
-1.3%
|
|
1Q14
|
-10,822
|
+22.4%
|
|
4Q13
|
-15,455
|
+2246.0%
|
|
3Q13
|
-30,878
|
+366.3%
|
|
2Q13
|
-10,853
|
+162.6%
|
|
1Q13
|
-8,845
|
+7.1%
|
|
4Q12
|
-659
|
-88.0%
|
|
3Q12
|
-6,623
|
+45.8%
|
|
2Q12
|
-4,134
|
+46.5%
|
|
1Q12
|
-8,255
|
-
|
|
4Q11
|
-5,477
|
-
|
|
3Q11
|
-4,542
|
-
|
|
2Q11
|
-2,823
|
-
|